AAAAAA

   
Results: 1-8 |
Results: 8
A PHASE-II TRIAL OF DEFEROXAMINE IN PATIENTS WITH HORMONE-REFRACTORY METASTATIC PROSTATE-CANCER
Authors: DREICER R KEMP JD STEGINK LD CARDILLO T DAVIS CS FOREST PK SEE WA
Citation: R. Dreicer et al., A PHASE-II TRIAL OF DEFEROXAMINE IN PATIENTS WITH HORMONE-REFRACTORY METASTATIC PROSTATE-CANCER, Cancer investigation, 15(4), 1997, pp. 311-317
RADIOIMMUNOTHERAPY OF EXPERIMENTAL PANCREATIC-CANCER WITH I-131-LABELED MONOCLONAL-ANTIBODY PAM4
Authors: GOLD DV CARDILLO T VARDI Y BLUMENTHAL R
Citation: Dv. Gold et al., RADIOIMMUNOTHERAPY OF EXPERIMENTAL PANCREATIC-CANCER WITH I-131-LABELED MONOCLONAL-ANTIBODY PAM4, International journal of cancer, 71(4), 1997, pp. 660-667
THE ABILITY OF ANTITRANSFERRIN RECEPTOR ANTIBODIES TO INHIBIT IRON UPTAKE IN TUMOR-CELLS APPEARS TO BE RELATED TO THE INITIAL CELL-SURFACE DENSITY THE RECEPTOR
Authors: CARDILLO T NAUMANN P STEWART B KEMP J
Citation: T. Cardillo et al., THE ABILITY OF ANTITRANSFERRIN RECEPTOR ANTIBODIES TO INHIBIT IRON UPTAKE IN TUMOR-CELLS APPEARS TO BE RELATED TO THE INITIAL CELL-SURFACE DENSITY THE RECEPTOR, The FASEB journal, 9(4), 1995, pp. 1045-1045
IRON DEPRIVATION TREATMENT OF MURINE LYMPHOMA IN-VITRO AND IN-VIVO - A COMPARISON OF PROTOCOLS USING EITHER ONE OR 2 IGG MONOCLONAL ANTITRANSFERRIN RECEPTOR ANTIBODIES WITH THE HYDROXYETHYL STARCH-DEFEROXAMINE
Authors: KEMP J CARDILLO T KERBERG E WEINER G NAUMANN P
Citation: J. Kemp et al., IRON DEPRIVATION TREATMENT OF MURINE LYMPHOMA IN-VITRO AND IN-VIVO - A COMPARISON OF PROTOCOLS USING EITHER ONE OR 2 IGG MONOCLONAL ANTITRANSFERRIN RECEPTOR ANTIBODIES WITH THE HYDROXYETHYL STARCH-DEFEROXAMINE, The FASEB journal, 9(3), 1995, pp. 206-206
INHIBITION OF LYMPHOMA GROWTH IN-VIVO BY COMBINED TREATMENT WITH HYDROXYETHYL STARCH DEFEROXAMINE CONJUGATE AND IGG MONOCLONAL-ANTIBODIES AGAINST THE TRANSFERRIN RECEPTOR
Authors: KEMP JD CARDILLO T STEWART BC KEHRBERG E WEINER G HEDLUND B NAUMANN PW
Citation: Jd. Kemp et al., INHIBITION OF LYMPHOMA GROWTH IN-VIVO BY COMBINED TREATMENT WITH HYDROXYETHYL STARCH DEFEROXAMINE CONJUGATE AND IGG MONOCLONAL-ANTIBODIES AGAINST THE TRANSFERRIN RECEPTOR, Cancer research, 55(17), 1995, pp. 3817-3824
INHIBITION OF TUMOR-GROWTH IN-VITRO AND IN-VIVO BY COMBINED TREATMENTWITH DEFEROXAMINE AND IGG MABS AGAINST THE TRANSFERRIN RECEPTOR
Authors: KEMP J NAUMANN P CARDILLO T KOVAR J
Citation: J. Kemp et al., INHIBITION OF TUMOR-GROWTH IN-VITRO AND IN-VIVO BY COMBINED TREATMENTWITH DEFEROXAMINE AND IGG MABS AGAINST THE TRANSFERRIN RECEPTOR, The FASEB journal, 8(4), 1994, pp. 10000504-10000504
CHARACTERIZATION OF MONOCLONAL-ANTIBODY PAM4 REACTIVE WITH A PANCREATIC-CANCER MUCIN
Authors: GOLD DV LEW K MALINIAK R HERNANDEZ M CARDILLO T
Citation: Dv. Gold et al., CHARACTERIZATION OF MONOCLONAL-ANTIBODY PAM4 REACTIVE WITH A PANCREATIC-CANCER MUCIN, International journal of cancer, 57(2), 1994, pp. 204-210
THE GROWTH INHIBITORY EFFECTS OF ANTITRANSFERRIN RECEPTOR ANTIBODIES APPEAR TO BE RELATED TO THE INITIAL CELL-SURFACE DENSITY OF TRANSFERRIN RECEPTORS
Authors: CARDILLO T SMITH K STEWART B NAUMANN P KEMP J
Citation: T. Cardillo et al., THE GROWTH INHIBITORY EFFECTS OF ANTITRANSFERRIN RECEPTOR ANTIBODIES APPEAR TO BE RELATED TO THE INITIAL CELL-SURFACE DENSITY OF TRANSFERRIN RECEPTORS, The Journal of immunology, 150(8), 1993, pp. 143-143
Risultati: 1-8 |